The Val34Leu genetic variation in the A Subunit of Coagulation Factor XIII in recurrent spontaneous abortion

References

• Anwar, R., Gallivan, L., Edmonds, S.D. and Markham, A.F. (1999) Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity. Blood 93(3):897–905.
   PubMed Web of Science ®Google Scholar
• Ariëns, R.A., Lai, T.S., Weisel, J.W., Greenberg, C.S. and Grant, P.J. (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100(3):743–754.
   PubMed Web of Science ®Google Scholar
• Attié-Castro, F.A., Zago, M.A., Lavinha, J., Elion, J., Rodriguez-Delfin, L., Guerreiro, J.F. and Franco, R.F. (2000) Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost 84(4):601–603.
   PubMed Web of Science ®Google Scholar
• Balogh, I., Szôke, G., Kárpáti, L., Wartiovaara, U., Katona, E., Komáromi, I., (2000) Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 96(7):2479–2486.
   PubMed Web of Science ®Google Scholar
• Barbosa, H.C., Carvalho, E.C., Barini, R., Siqueira, L.H., Costa, D.S. and Annichino-Bizzacchi, J.M. (2004) Tyr204Phe and Val34Leu polymorphisms in two Brazilian ethnic groups and in patients with recurrent miscarriages. Fertil Steril 82(5):1455–1457.
   PubMed Web of Science ®Google Scholar
• Board, P.G., Webb, G.C., McKee, J., and Ichinose, A. (1988) Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24–p25. Cytogenet Cell Genet 48(1): 25–27.
   PubMedGoogle Scholar
• Catto, A.J., Kohler, H.P., Coore, J., Mansfield, M.W., Stickland, M.H. and Grant, P.J. (1999) Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 93(3):906–908.
   PubMed Web of Science ®Google Scholar
• Cho, K.H., Kim, B.C., Kim, M.K., Shin and B.A. (2002) No association of factor XIII Val34Leu polymorphism with primary intracerebral hemorrhage and healthy controls in Korean population. J Korean Med Sci 17: 249–253.
   PubMed Web of Science ®Google Scholar
• Chung, S.I., Lewis, M.S. and Folk, J.E. (1974) Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures. J Biol Chem 249(3): 940–950.
   PubMed Web of Science ®Google Scholar
• Coulam, C.B., Jeyendran, R.S., Fishel, L.A. and Roussev, R. (2006) Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol 55(5):360–368.
   PubMed Web of Science ®Google Scholar
• Cross, J.C., Werb, Z. and Fisher, S.J. (1994) Implantation and the placenta: key pieces of the development puzzle. Science 266(5190):1508–1518.
   PubMed Web of Science ®Google Scholar
• Dossenbach-Glaninger, A., van Trotsenburg, M., Schneider, B., Oberkanins, C., and Hopmeier, P. (2008) ACE I/D polymorphism and recurrent first trimester pregnancy loss: interaction with SERPINE1 4G/5G and F13 Val34Leu polymorphisms. Br J Haematol; 141(2):269–271.
   PubMed Web of Science ®Google Scholar
• Dossenbach-Glaninger, A., van Trotsenburg, M., Dossenbach, M., Oberkanins, C., Moritz, A., Krugluger, W., (2003) Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 49(7):1081–1086.
   PubMed Web of Science ®Google Scholar
• Duckert, F. (1972) Documentation of the plasma factor XIII deficiency in man. Ann N Y Acad Sci 202:190–199.
   PubMed Web of Science ®Google Scholar
• Elbaz, A., Poirier, O., Canaple, S., Chédru, F., Cambien, F. and Amarenco, P. (2000) The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood 95(2):586–591.
   PubMed Web of Science ®Google Scholar
• Feng, Q., Liu, Y., Liu, K., Byrne, S., Liu, G., Wang, X., (2000) Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation. Placenta 21(2–3):184–193.
   PubMed Web of Science ®Google Scholar
• Floridon, C., Nielsen, O., Hølund, B., Sweep, F., Sunde, L., Thomsen, S.G. and Teisner, B. (2000) Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta 21(8):754–762.
   PubMed Web of Science ®Google Scholar
• Franco, R.F., Middeldorp, S., Meinardi, J.R., van Pampus, E.C. and Reitsma, P.H. (2000) Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers. Br J Haematol 111(1):118–121.
   PubMed Web of Science ®Google Scholar
• Goodman, C.S., Coulam, C.B., Jeyendran, R.S., Acosta, V.A. and Roussev, R. (2006) Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol 56(4):230–236.
   PubMed Web of Science ®Google Scholar
• Ichinose, A. and Davie, E.W. (1988) Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci USA 85(16):5829–5833.
   PubMed Web of Science ®Google Scholar
• Ivaskevicius, V., Biswas, A., Bevans, C., Schroeder, V., Kohler, H.P., Rott, H., (2010) Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica 95(6):956–962.
   Google Scholar
• Ivaskevicius, V., Biswas, A., Loreth, R., Schroeder, V., Ohlenforst, S., Rott, H., (2010) Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia 16(4):675–82.
   PubMed Web of Science ®Google Scholar
• Ivaskevicius, V., Seitz, R., Kohler, H.P., Schroeder, V., Muszbek, L., Ariens, R.A., (2007) International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 97(6): 914–921.
   PubMed Web of Science ®Google Scholar
• Jeddi-Tehrani, M., Torabi, R., Mohammadzadeh, A., Arefi, S., Keramatipour, M., Zeraati, H., (2010) Investigating Association of Three Polymorphisms of Coagulation Factor XIII and Recurrent Pregnancy Loss. Am J Reprod Immunol 64(3):212–217.
   PubMed Web of Science ®Google Scholar
• Kangsadalampai, S. and Board, P.G. (1998) The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 92:2766–2770.
   PubMed Web of Science ®Google Scholar
• Kohler, H.P., Ariëns, R.A., Whitaker, P. and Grant, P.J. (1998) A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 80(4):704.
   Google Scholar
• Kohler, H.P. and Grant, P.J. (1998) Clustering of haemostatic risk factors with FXIIIVal34Leu in patients with myocardial infarction. Thromb Haemost 80(5):862.
   Google Scholar
• Kohler, H.P., Stickland, M.H., Ossei-Gerning, N., Carter, A., Mikkola, H. and Grant, P.J. (1998) Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 79(1):8–13.
   Google Scholar
• Lewis, S.D., Janus, T.J., Lorand, L. and Shafer, J.A. (1985) Regulation of formation of factor XIIIa by its fibrin substrates. Biochemistry 24(24):6772–6777.
   Google Scholar
• López Ramírez, Y., Vivenes, M., Miller, A., Pulido, A., López Mora, J., Arocha-Piñango, C.L. and Marchi, R. (2006) Prevalence of the coagulation factor XIII polymorphism Val34Leu in women with recurrent miscarriage. Clin Chim Acta 374(1-2):69–74.
   PubMed Web of Science ®Google Scholar
• Lorand, L., Losowsky, M.S., and Miloszewski, K.J.M. (1980) Human factor XIII fibrin stabilising factor. Progr Thromb Haemost 5:245–290.
   Google Scholar
• Meyer, M. (2004) Molecular biology of haemostasis: fibrinogen, factor XIII. Hamostaseologie 24: 108–115.
   PubMedGoogle Scholar
• Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215.
   Google Scholar
• Muszbek, L. (2000) Deficiency causing mutations and common polymorphisms in the factor XIII-A gene. Thromb Haemost 84:524–527.
   PubMed Web of Science ®Google Scholar
• Rallidis, L.S., Politou, M., Komporozos, C., Panagiotakos, D.B., Belessi, C.I., Travlou, (2008) Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Thromb Haemost 99(6):1085–1089.
   PubMed Web of Science ®Google Scholar
• Shafey, M., Anderson, J.L., Scarvelis, D., Doucette, S.P., Gagnon, F. and Wells, P.S. (2007) Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis. Thromb Haemost 97(4):635–641.
   PubMed Web of Science ®Google Scholar
• Suzuki, K., Henke, J., Iwata, M., Henke, L., Tsuji, H., Fukunaga, G.I., (1996) Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit gene. Hum Genet 98:393–395.
   PubMed Web of Science ®Google Scholar
• Vossen, C.Y., and Rosendaal, F.R. (2005) The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level. J Thromb Haemost 3(5):1102–1103.
   PubMed Web of Science ®Google Scholar
• Wartiovaara, U., Perola, M., Mikkola, H., Tötterman, K., Savolainen, V., Penttilä, A., (1999) Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 142(2):295–300.
   PubMed Web of Science ®Google Scholar
• Webb, G.C., Coggan, M., Ichinose, A. and Board, P.G. (1989) Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31-32.1 and restriction fragment length polymorphism at the locus. Hum Genet 81(2):157–160.
   PubMed Web of Science ®Google Scholar
• Wells, P.S., Anderson, J.L., Scarvelis, D.K., Doucette, S.P. and Gagnon, F. (2006) Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol 164(2):101–109.
   PubMed Web of Science ®Google Scholar